Source: The Pharma Letter

Alder BioPharmaceuticals: Look back at pharma news in the week to September 20

The news last week that Denmark's Lundbeck is to acquire Alder Biopharmaceuticals and its migraine...

Read full article »
Alder BioPharmaceuticals's Competitors | Alder BioPharmaceuticals's News | Alder BioPharmaceuticals's Financials
Stay up-to-date with the latest news on Alder BioPharmaceuticals
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Robert W. Azelby's photo - President & CEO of Alder BioPharmaceuticals

President & CEO

Robert W. Azelby

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Alder BioPharmaceuticals